Price Alert

Quanterix Corporation (QTRX)

NASDAQ: QTRX · Real-Time Price · USD

4.79

0.46 (10.62%)

At close: Sep 11, 2025, 3:59 PM

4.79

0.00%

After-hours: Sep 11, 2025, 04:04 PM EDT

10.62% (1D)

Bid	4.61
Market Cap	222.57M
Revenue (ttm)	125.38M
Net Income (ttm)	-70.5M
EPS (ttm)	-1.81
PE Ratio (ttm)	-2.65
Forward PE	-3.43
Analyst	Hold

Ask	5.25
Volume	1,192,181
Avg. Volume (20D)	730,180
Open	4.33
Previous Close	4.33
Day's Range	4.33 - 4.80
52-Week Range	4.05 - 15.86
Beta	1.03

About QTRX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol QTRX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for QTRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

5 months ago

-1.79%

Quanterix Corporation shares are trading lower aft... Unlock content with Pro Subscription

10 months ago

-18.26%

Quanterix shares are trading lower. The company reported Q3 financial results.

News

3 weeks ago · businesswire.com

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the New York State Departmen...

4 weeks ago · zacks.com

Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX)

Quanterix (QTRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising...

1 month ago · businesswire.com

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

1 month ago · seekingalpha.com

Quanterix Corporation (QTRX) Q2 2025 Earnings Call Transcript

Quanterix Corporation (NASDAQ:QTRX ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 AM ET Company Participants Joshua Young - Corporate Participant Masoud Toloue - President, CEO & Director Vand...

1 month ago · zacks.com

Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates

Quanterix Corporation (QTRX) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of $0.25 per share a year ago.

1 month ago · businesswire.com

Quanterix Announces Cooperation Agreement with Kent Lake Capital

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announc...

1 month ago · businesswire.com

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

2 months ago · businesswire.com

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announ...